Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Lactams. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112300047A reveals a novel Ru-catalyzed tandem reductive amination for chiral lactams, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN111925356A discloses stable chiral ligands enabling high-yield nickel-catalyzed lactam synthesis, offering cost reduction in API manufacturing and reliable supply chain solutions.